查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1316525

充血性心臟衰竭治療設備市場：按產品、最終用戶分類 - 2023-2030 年全球預測

Congestive Heart Failure Treatment Device Market by Product, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球充血性心臟衰竭治療設備市場預計到2023年將大幅成長，達到124.4億美元，年複合成長率為8.14%，預計到2030年將達到215.4億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球充血性心臟衰竭治療器材市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 充血性心臟衰竭治療設備的全球市場規模和預測是多少？

2.在預測期內，COVID-19 對全球充血性心臟衰竭治療設備市場的阻礙因素與影響有哪些？

3.在預測期內，全球充血性心臟衰竭治療設備市場需要投資哪些產品/細分市場/應用/領域？

4.全球充血性心臟衰竭治療器材市場的競爭策略是什麼？

5.全球充血性心臟衰竭治療器材市場的技術趨勢和法律規範是什麼？

6.全球充血性心臟衰竭治療設備市場主要供應商的市佔率為何？

7. 哪些型態和策略性措施被認為適合進入全球充血性心臟衰竭治療器材市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 生活方式的改變更容易導致心臟衰竭和心律不整
      • 更加關注心臟相關疾病的早期和初步診斷
      • 政府努力提高人們對心血管疾病的認知
    • 抑制因素
      • 偏好相對昂貴的設備和藥品
    • 機會
      • 政府增加對 CHF 設備的批准
      • CHF治療設備的技術進步
    • 任務
      • 嚴格的法規核准流程
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 充血性心臟衰竭治療設備市場：副產品

  • 心臟再同步治療
    • 心臟再同步治療－心臟去顫器
    • 心臟再同步治療-起搏器
  • 植入式心臟整流去顫器
    • 植入式心臟整流去顫器
    • 植入式心臟整流去顫器
  • 起搏器
  • 心室輔助裝置
    • 雙心室輔助裝置
    • 左心室輔助裝置
    • 右心室輔助裝置

第7章 充血性心臟衰竭治療設備市場：依最終使用者分類

  • 門診手術中心
  • 醫院和診所

第8章 美洲充血性心臟衰竭治療設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太充血性心臟衰竭治療設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲充血性心臟衰竭治療器材市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第12章上市公司名單

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-036CEF508589

The Global Congestive Heart Failure Treatment Device Market is forecasted to grow significantly, with a projected USD 12.44 billion in 2023 at a CAGR of 8.14% and expected to reach a staggering USD 21.54 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Congestive Heart Failure Treatment Device Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Congestive Heart Failure Treatment Device Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillator, Pacemaker, and Ventricular Assist Device. The Cardiac Resynchronization Therapy is further studied across Cardiac Resynchronization Therapy-Defibrillator and Cardiac Resynchronization Therapy-Pacemaker. The Implantable Cardioverter Defibrillator is further studied across Subcutaneous Implantable Cardioverter Defibrillator and Transvenous Implantable Cardioverter Defibrillator. The Ventricular Assist Device is further studied across Biventricular Assist Device, Left Ventricular Assist Device, and Right Ventricular Assist Device. The Pacemaker is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgery Center and Hospitals & Clinics. The Ambulatory Surgery Center is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Congestive Heart Failure Treatment Device Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Congestive Heart Failure Treatment Device Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Congestive Heart Failure Treatment Device Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Congestive Heart Failure Treatment Device Market?

4. What is the competitive strategic window for opportunities in the Global Congestive Heart Failure Treatment Device Market?

5. What are the technology trends and regulatory frameworks in the Global Congestive Heart Failure Treatment Device Market?

6. What is the market share of the leading vendors in the Global Congestive Heart Failure Treatment Device Market?

7. What modes and strategic moves are considered suitable for entering the Global Congestive Heart Failure Treatment Device Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Congestive Heart Failure Treatment Device Market, by Product, 2022 vs 2030
  • 4.3. Congestive Heart Failure Treatment Device Market, by End-User, 2022 vs 2030
  • 4.4. Congestive Heart Failure Treatment Device Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing susceptibility to heart failure and arrhythmia owing to changing lifestyles
      • 5.1.1.2. Increasing focus on early and primary diagnosis of heart-related disorders
      • 5.1.1.3. Government initiatives spreading awareness on cardiovascular diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively expensive devices and preference for drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising government approvals for CHF devices
      • 5.1.3.2. Technological advancements in CHF treatment devices
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory approval process
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Congestive Heart Failure Treatment Device Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Resynchronization Therapy
    • 6.2.1. Cardiac Resynchronization Therapy-Defibrillator
    • 6.2.2. Cardiac Resynchronization Therapy-Pacemaker
  • 6.3. Implantable Cardioverter Defibrillator
    • 6.3.1. Subcutaneous Implantable Cardioverter Defibrillator
    • 6.3.2. Transvenous Implantable Cardioverter Defibrillator
  • 6.4. Pacemaker
  • 6.5. Ventricular Assist Device
    • 6.5.1. Biventricular Assist Device
    • 6.5.2. Left Ventricular Assist Device
    • 6.5.3. Right Ventricular Assist Device

7. Congestive Heart Failure Treatment Device Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgery Center
  • 7.3. Hospitals & Clinics

8. Americas Congestive Heart Failure Treatment Device Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Congestive Heart Failure Treatment Device Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Congestive Heart Failure Treatment Device Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 6. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET DYNAMICS
  • FIGURE 8. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 6. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 10. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 15. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY BIVENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 232. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 233. CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET LICENSE & PRICING